Delphinus Medical Technologies

Delphinus Medical Technologies

Private
Novi, MichiganHealthcare & Life Scienceshttps://www.delphinusmt.com

Last Round

Series D

Extension

Apr 3, 2025

Total Funding Raised

$131.76M

Company Overview

Delphinus Medical Technologies is a healthcare company that develops an innovative ultrasound system aimed at enhancing the early detection of breast cancer by accurately distinguishing between benign and malignant masses using sound and water technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

ultrasound tomographywhole breast ultrasounddense breast screeningmedical imaging devicebreast cancer screening3D breast ultrasoundsupplemental breast screeningcompression-free imagingno-squish mammogramradiation-free imagingFDA premarket approvalPMAdiagnostic imagingmedical tomographyTriAD technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Delphinus Medical Technologies Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Delphinus Medical Technologies Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series D ExtensionApr 3, 2025
DebtAug 22, 2023
DebtJun 22, 2023
Series DSep 29, 2022
Series CSep 10, 2015
Series B
Sep 12, 2013

Delphinus Medical Technologies Investors

Notable investors and investment history

InvestorRounds
North Coast Technology InvestorsSeries A, Series D, Series B, Series C
Arboretum VenturesSeries D, Series C, Series B, Series A
Waycross VenturesSeries D, Series C
BeringeaSeries D, Series C, Series A, Series B
Venture Investors LLCSeries D, Series C
Trinity CapitalDebt
Hopen Life Science VenturesSeries D, Series C

Delphinus Medical Technologies Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Delphinus Medical Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Delphinus Medical Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersNovi, Michigan
Employee Range21
Year Founded2010
Last FundingApr 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.